OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
Xiaojuan Sun, Weidong Chen, Yan‐Dong Wang
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 258

Showing 1-25 of 258 citing articles:

Neuronal Cell Death
Michael Fricker, Aviva M. Tolkovsky, Vilmantė Borutaitė, et al.
Physiological Reviews (2018) Vol. 98, Iss. 2, pp. 813-880
Open Access | Times Cited: 916

Biological Activities of Stilbenoids
Bolanle C. Akinwumi, Kimberly-Ann Bordun, H. D. Anderson
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 792-792
Open Access | Times Cited: 307

Therapies for Prevention and Treatment of Alzheimer’s Disease
Jesus Mendiola-Precoma, Laura C. Berumen, Karla Padilla, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-17
Open Access | Times Cited: 225

DAF-16/FOXO Transcription Factor in Aging and Longevity
Xiaojuan Sun, Weidong Chen, Yan‐Dong Wang
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 205

Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier
Ka Hong Wong, Muhammad Kashif Riaz, Yuning Xie, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 381-381
Open Access | Times Cited: 173

Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?
Tamàs Fülöp, Jacek M. Witkowski, Karine Bourgade, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 167

The promise of music therapy for Alzheimer's disease: A review
Anna Maria Matziorinis, Stefan Koelsch
Annals of the New York Academy of Sciences (2022) Vol. 1516, Iss. 1, pp. 11-17
Open Access | Times Cited: 73

Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs
Samridhi Thakral, Alka Yadav, Vikramjeet Singh, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101960-101960
Closed Access | Times Cited: 51

Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 18

The duality of amyloid-β: its role in normal and Alzheimer’s disease states
Ali Azargoonjahromi
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 17

Role of the peripheral innate immune system in the development of Alzheimer's disease
Aurélie Le Page, Gilles Dupuis, Éric Frost, et al.
Experimental Gerontology (2017) Vol. 107, pp. 59-66
Closed Access | Times Cited: 139

Long noncoding RNAs and Alzheimer's disease
Qiong Luo, Yinghui Chen
Clinical Interventions in Aging (2016) Vol. Volume 11, pp. 867-872
Open Access | Times Cited: 138

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
Tosin A. Olasehinde, Ademola O. Olaniran, Anthony I. Okoh
Molecules (2017) Vol. 22, Iss. 3, pp. 480-480
Open Access | Times Cited: 118

In vitro neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation
Shadab Md, Sook Yee Gan, Yong Hong Haw, et al.
International Journal of Biological Macromolecules (2018) Vol. 118, pp. 1211-1219
Closed Access | Times Cited: 103

NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer’s Disease
Mariana Van Zeller, Diogo Dias, Ana M. Sebastião, et al.
Journal of Alzheimer s Disease (2021) Vol. 83, Iss. 3, pp. 939-961
Open Access | Times Cited: 93

Protein aggregation and ER stress
Navit Ogen‐Shtern, Tamuz Ben David, Gerardo Z. Lederkremer
Brain Research (2016) Vol. 1648, pp. 658-666
Closed Access | Times Cited: 90

Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
Jade de Oliveira, Ewa Kucharska, Michelle Lima Garcez, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2581-2581
Open Access | Times Cited: 63

Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
Andrila E. Collins, Tarek M. Saleh, Bettina E. Kalisch
Antioxidants (2022) Vol. 11, Iss. 2, pp. 213-213
Open Access | Times Cited: 61

BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?
Firas H. Bazzari, Amjad H. Bazzari
Molecules (2022) Vol. 27, Iss. 24, pp. 8823-8823
Open Access | Times Cited: 48

Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
Mladena Glavaš, Agata Gitlin‐Domagalska, Dawid Dębowski, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3068-3068
Open Access | Times Cited: 41

Amyloid-beta and tau protein beyond Alzheimer’s disease
Morteza Abyadeh, Vivek Gupta, João A. Paulo, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1262-1276
Open Access | Times Cited: 37

Marine Macroalgae Polyphenols as Potential Neuroprotective Antioxidants in Neurodegenerative Diseases
Silvia Lomartire, Ana M. M. Gonçalves
Marine Drugs (2023) Vol. 21, Iss. 5, pp. 261-261
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top